Quest Laboratories Limited (NSE:QUESTLAB)
India · Delayed Price · Currency is INR 111.90
+1.70 (1.54%)
Mar 5, 2026, 3:24 PM IST
Quest Laboratories Revenue
Quest Laboratories had revenue of 306.12M INR in the quarter ending December 31, 2025, with 106.32% growth. This brings the company's revenue in the last twelve months to 1.26B, up 61.55% year-over-year. In the fiscal year ending March 31, 2025, Quest Laboratories had annual revenue of 1.04B with 25.92% growth.
Revenue (ttm)
1.26B
Revenue Growth
+61.55%
P/S Ratio
1.43
Revenue / Employee
25.18M
Employees
50
Market Cap
1.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04B | 214.03M | 25.92% |
| Mar 31, 2024 | 825.63M | 209.22M | 33.94% |
| Mar 31, 2023 | 616.41M | 21.57M | 3.63% |
| Mar 31, 2022 | 594.84M | 291.20M | 95.91% |
| Mar 31, 2021 | 303.63M | 39.84M | 15.10% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 7.48B |
| Accent Microcell | 2.78B |
| Infinium Pharmachem | 1.57B |
| Zenith Drugs | 1.44B |
| Sotac Pharmaceuticals | 846.72M |
| Sunrest Lifescience | 520.34M |
| Medicamen Organics | 394.30M |
| Vilin Bio Med | 199.81M |